跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SANDOZ CIPROFLOXACIN / DEXAMETHASONE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SANDOZ CIPROFLOXACIN / DEXAMETHASONE
Authorized
STANDARD
SANDOZ CIPROFLOXACIN / DEXAMETHASONE
Sandoz Canada, Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b508c1ef53154fee
Company
Sandoz Canada, Inc.
Type
Standard
Approval Details
Approval Id
b508c1ef53154fee
Drug Approval Canada Name
SANDOZ CIPROFLOXACIN / DEXAMETHASONE
Product Name
SANDOZ CIPROFLOXACIN / DEXAMETHASONE
Status
Marketed
Status Date
2021-01-26
Original Market Date
2021-01-26
Din
02506882
Drug Class
Human
Dosage Form
Suspension
Route Of Administration
Otic
Schedule
Prescription
Ahfs
52:08.08
Atc Original
S02CA06 DEXAMETHASONE AND ANTIINFECTIVES
Atc Name
s 02 ca 06
Aig Number
0250083001
Company Name
Sandoz Canada, Inc.
Company Address
4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path
/organization/sandoz-canada-inc
Company Information
Pharmaceutical Company Name
Sandoz Canada, Inc.
Country Name
Canada
Website
http://www.sandoz.ca
Active Ingredients
DEXAMETHASONE
0.1 % / W/V
CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE)
0.3 % / W/V
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b508c1ef53154fee
Type
Standard
Back to Health Canada Approvals